Mark’ennovy completes Growth Funding

October 26, 2018 Posted by Mark’ennovy


Mark’ennovy Personalized Care, European-based provider of precision contact lenses, is pleased to announce the completion of a significant debt and equity funding package. Bond Capital Partners, a London based, independent investor and advisor to small and medium-sized businesses has acquired a notable interest in the Group.  In parallel, additional debt finance was provided by Alantra, a global mid-market investment banking and asset management firm.

George Sarrouf, Chairman, CEO and majority shareholder of Mark’ennovy, commented: “This newly founded alliance allows us to accelerate new product development focused on an almost infinite choice of daily and monthly soft contact lenses. With a significantly wider range of materials, geometries and parameters we will provide access to contact lens wear that previously was unavailable.”

London-based firm, Bond Capital Partners, brings a wealth of experience in contact lenses having previously invested in the European eye-care industry. Comments Mark Opzoomer CEO of Bond Capital Partners, “Mark’ennovy has a powerful, but understated position in the market. The company has the potential to provide practitioners with a unique product range disrupting the ‘one size fits all’ mentality to one which provides precision-based solutions.”

The partnership with Bond Capital Partners and Alantra Private Debt follows the successful launch of Versa One Day Toric, Mark’ennovy’s first endeavour into daily disposable contact lenses. Versa provides practitioners with a wider range of cylinders, spheres and axes in the increasingly pre-dominant daily disposable lens market. This will better serve a larger contact lens wearer population that would otherwise be required to wear monthly disposable contact lenses.

Next entry: Successful CLMA Business Retreat

Previous entry: Thomas E. Anastor has passed away.

Leave a comment:

Commenting is not available in this weblog entry.